Rationale: Several guidelines exist that address treatment of patients with nonmetastatic muscle-invasive bladder cancer (MIBC). However, most only briefly mention follow-up strategies for patients and hence the treating physician is often left to infer on what the preferred follow-up schema would be for an individual patient. Herein, we aim to synthesize recommendations for follow-up of patients with MIBC for easy reference. Methods: A multidisciplinary MIBC expert panel from the International Bladder Cancer Network was assembled to critically assess currently available major guidelines on surveillance of MIBC patients. Recommendations for follow-up were extracted and critically evaluated. Important considerations for guideline assessment included both aspects of oncological and functional follow-up-frequency of visits, the use of different imaging modalities, the role of cytology and molecular markers, and the duration of follow-up. Outcome: An International Bladder Cancer Network expert consensus recommendation was constructed for the follow-up of patients with MIBC based on the currently available evidence-based data.

, , , ,
doi.org/10.1016/j.urolonc.2018.01.014, hdl.handle.net/1765/104928
Urologic Oncology

Zuiverloon, T., van Kessel, K., Bivalacqua, T.J. (Trinity J.), Boormans, J., Ecke, T.H. (Thorsten H.), Grivas, P.D. (Petros D.), … Kamat, A.M. (Ashish M.). (2018). Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network. Urologic Oncology. doi:10.1016/j.urolonc.2018.01.014